Point of care

2024 Computed Tomography (CT) Market Research With Executive and Consultant Guides: Mobile and Point of Care are Taking a New Lead - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 2, 2024
Biotechnology, Health Technology, Health, Photon, CT scan, Consultant, Point, Dental, Place, Research, Hospital, Growth, Point of care, Application, Medical imaging

The "Computed Tomography (CT) Markets by Application, by Technology, by Place and by Product With Executive and Consultant Guides" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Computed Tomography (CT) Markets by Application, by Technology, by Place and by Product With Executive and Consultant Guides" report has been added to ResearchAndMarkets.com's offering.
  • Now Mobile and Point of Care are taking a new lead.
  • This exciting imaging market is driving into new territory driven by greater capability and impressive medical research results.
  • A detailed breakout for any country in the world is available to purchasers of the report.

PatientPoint Becomes First Point-of-Care Publisher to Earn Media Rating Council Accreditation

Retrieved on: 
Tuesday, January 30, 2024
Nielsen, DCR, Point of care, Meta, Name, Data collection, Accreditation, Media Rating Council, MRC, Disclosure

PatientPoint is the first Point-of-Care publisher to receive accreditation for its reported metrics by the media industry's foremost independent measurement authority.

Key Points: 
  • PatientPoint is the first Point-of-Care publisher to receive accreditation for its reported metrics by the media industry's foremost independent measurement authority.
  • PatientPoint joins some of the most recognizable names in traditional and digital media channels such as Google, Nielsen and Meta in receiving MRC accreditation for metrics supporting specific products.
  • "Receiving accreditation from the most respected media measurement authority should give sponsors full confidence in our business metrics and delivery guarantees.
  • Importantly, we believe MRC accreditation further underscores why Point of Care should be viewed as a foundational component of any life sciences brand media mix."

Fujirebio and Agappe Enter into an Agreement on Business Collaboration in the Field of CLIA Based Immunoassay

Retrieved on: 
Friday, January 19, 2024
Oncology, Health, Consumer, Infectious Diseases, Baby, Maternity, General Health, Cardiology, Point of care, CLIA, Partnership, Point, Infection, Biomarker, CDMO, Cartridge, Neurodegenerative disease, Medical device

Notably, the analyzers and reagents will be sold under Agappe’s brand, making Agappe the first Indian local company with a complete Chemiluminescence Solution comprising locally manufactured reagents.

Key Points: 
  • Notably, the analyzers and reagents will be sold under Agappe’s brand, making Agappe the first Indian local company with a complete Chemiluminescence Solution comprising locally manufactured reagents.
  • In a significant move, Agappe and Fujirebio have revealed plans to launch these products in June 2024.
  • The project has already achieved significant progress, including the signing of a Supply and License Agreement in March 2023.
  • Agappe is at the advanced stages of technical transfer from Fujirebio, enabling them to manufacture Chemiluminescence Reagents using Fujirebio’s technology and materials.

LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche

Retrieved on: 
Friday, December 29, 2023
Health, Goldman Sachs, Sale, LLP, Acquisition, Form, FTI Consulting, USD, Point of care, Véronique, Patient, Pharmaceutical industry

The administrators have signed a definitive agreement to sell certain companies of the LumiraDx group related to LumiraDx’s innovative point of care technology to Roche.

Key Points: 
  • The administrators have signed a definitive agreement to sell certain companies of the LumiraDx group related to LumiraDx’s innovative point of care technology to Roche.
  • The appointed administrators entered into a definitive agreement for Roche to acquire certain companies of the LumiraDx group engaged in its point of care diagnostics platform business and certain related assets.
  • Veronique Ameye, Chief Executive Officer of LumiraDx said, “Since our founding, we have sought to transform community-based healthcare by consolidating multiple Point of Care tests on a single instrument.
  • We are excited to enter into this agreement with Roche as it will enable us to continue our important work and increase the reach of our innovative technology around the globe.

The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition - COVID-19 Impact, Regions of Market Influence and What to Watch For Long-Term - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 27, 2023
Infectious Diseases, Biotechnology, Health, COVID-19, Infection, Histology, Government, Research, Market, Test management, Size, Projection, Point, Point of care, Blood bank, IVD, Medical device

The "Worldwide Market for In Vitro Diagnostic Tests, 16th Edition" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Worldwide Market for In Vitro Diagnostic Tests, 16th Edition" report has been added to ResearchAndMarkets.com's offering.
  • The 16th edition of The Worldwide Market for In Vitro Diagnostic Tests is based on vendor reporting, interviews, vendor activities, and more on a global scale.
  • The 16th edition of the Worldwide Market for In Vitro Diagnostic Tests is a must have for anyone interested or involved in the IVD industry.
  • The 16th edition of the Worldwide Market for In Vitro Diagnostic Tests provides readers with reliable estimates, real-world forecasts, and insights needed to understand the IVD market in its entirety.

CorVista Health Announces AHA Presentation of Machine Learning to Detect Pulmonary Hypertension at Point-of-Care

Retrieved on: 
Sunday, November 12, 2023
Women, Seniors, Parenting, Research, Software, Family, Consumer, Science, Social Media, Technology, Search Engine Optimization, Search Engine Marketing, Cardiology, Blogging, General Health, Publishing, Public Relations, Investor Relations, Health, Communications, Machine learning, Disease, Heart, AUC, Pulmonary hypertension, Point, AHA, Mortality, Cardiovascular disease, Patient, Multimedia, TTE, Echocardiography, FDA, Orthostatic hypertension, Point of care, Heart failure, Coronary artery disease, PPG, Diagnosis, Learning, PAH, OVG, HIV disease progression rates, Pharmaceutical industry

CorVista Health AHA Presentation--Machine Learning to Detect Pulmonary Hypertension at Point of Care. Presented by Dr. Charles Bridges. (Photo: Business Wire)

Key Points: 
  • CorVista Health, Inc. , a leading digital health company dedicated to improving cardiovascular disease diagnosis, is pleased to announce the presentation of Machine Learning to Detect Pulmonary Hypertension data at AHA.
  • View the full release here: https://www.businesswire.com/news/home/20231112489250/en/
    CorVista Health AHA Presentation--Machine Learning to Detect Pulmonary Hypertension at Point of Care.
  • (Photo: Business Wire)
    “We are pleased to present this important data at this year’s AHA meeting.” said Don Crawford, President and CEO of CorVista Health.
  • “We believe the CorVista System® can make a tremendous impact to patients suffering from pulmonary hypertension, especially in rural and underserved populations.”

RICOH 3D for Healthcare partners with Materialise to broaden access to 3D-printed patient-specific solutions

Retrieved on: 
Monday, November 27, 2023
3D printing, Merge, Annual general meeting, Food, Federal Medical Centres, Point of care, CMF, Patient, Managed services, ISO, FDA, Ecosystem, Printing, Workflow, Stratasys, RICOH, Partnership, 3D, Hospital, Physician, Health, Merative, DICOM, Medical imaging, Ricoh, Health care

EXTON, Pa., Nov. 27, 2023 /PRNewswire/ -- Ricoh USA, Inc. today announced at the RSNA Assembly and Annual Meeting, a partnership with Materialise that will provide software solutions to support RICOH 3D for Healthcare (Booth #8300) – a HIPAA-compliant, ISO 13485 certified 3D medical manufacturing center for the development, design and production of 3D-printed anatomic models – in both their centralized medical device manufacturing facility, as well as in Ricoh's Point of Care facilities. Through the partnership, Ricoh will now be able to drive more personalized healthcare solutions and make it simple to create or expand on-site Point of Care centers.

Key Points: 
  • A main driver of either option is co-located management of facilities and production through partners such as Ricoh with technologies like those from Materialise.
  • Ricoh is partnering with Materialise to leverage their leading software solutions to bring affordable Point of Care 3D printing services to hospitals across the country.
  • Stratasys: RICOH 3D for Healthcare engages in a strategic collaboration with Stratasys to leverage their 3D printing technology to expand access to 3D-printed medical models.
  • RICOH 3D for Healthcare is taking a phased approach to integrate Point of Care manufacturing into healthcare systems nationally, thereby creating a nationwide ecosystem for networking and cross-system collaboration.

InStep Health Enhances Retail Practice with the Addition of Jason Wilkinson as Senior Vice President of Retail and Client Solutions

Retrieved on: 
Wednesday, October 4, 2023
Wilkinson, GSK, Foot, Senior, Education, Pharmacy, Rite Aid, Pharmacist, Patient, Knowledge, Publicis Healthcare Communications Group, Growth, Point of care, Kmart

CHICAGO, Oct. 4, 2023 /PRNewswire/ -- InStep Health, the leader in healthcare communications, welcomes Jason Wilkinson as its new Senior Vice President of Retail and Client Solutions.

Key Points: 
  • CHICAGO, Oct. 4, 2023 /PRNewswire/ -- InStep Health, the leader in healthcare communications, welcomes Jason Wilkinson as its new Senior Vice President of Retail and Client Solutions.
  • InStep Health assists pharmaceutical, over the counter, and consumer-packaged brands in leveraging a continuum of connections to reach consumers at the Point of Care.
  • Whether in the doctor's office, pharmacy, or the aisles, InStep Health provides a seamless connection between brands, healthcare providers, pharmacists, patients, and consumers.
  • In addition, Wilkinson's role will be critical to managing several components of the InStep Health omnichannel network.

Aditxt, Inc. (NASDAQ: ADTX) Provides Shareholder Update and Planned Strategy for Achieving Commercial Scale

Retrieved on: 
Friday, August 18, 2023
Biotechnology, Other Health, Diabetes, Health, General Health, Medical Devices, Research, Infectious Diseases, Surgery, Science, Clinical Trials, Inc., GMP, DTC, Stiff-person syndrome, DNA, Allergy, Pharyngealization, Mayo Clinic, Central nervous system, Therapy, Life, Clinical trial, Genetics, STI, Marketing, Urinary tract infection, Genomics, Safety, COVID-19, Direct-to-consumer advertising, Point of care, Favipiravir, CTA, Infection, E-commerce, Autoimmunity, Psoriasis, Nature, RSV, Acquisition, Patient, Organ transplantation, Immune system, Medicine, Viral, Entrepreneurship, Clinical professor, Neurology, Skin, Social media, Software, Vaccine, Pharmaceutical industry, T1D

For Q2 2023 and the first half of the Q3 2023, we have been heavily focused on ongoing conversations around promising innovations.

Key Points: 
  • For Q2 2023 and the first half of the Q3 2023, we have been heavily focused on ongoing conversations around promising innovations.
  • We also mutually agreed to terminate the non-binding letter of intent with Natural State Genomics and Natural State Laboratories.
  • Since the founding of Aditxt, we have believed that commercializing health innovations deserves a new approach driven by stakeholders.
  • Continuing to expand product pipeline, research, and development, and have wider commercial reach with patients with a POC testing platform.

PatientPoint Launches Audience Builder Precision Targeting Solution to Connect Life Science Brands to Every Possible Patient

Retrieved on: 
Wednesday, August 9, 2023
Point of care, Health, Point, Builder, Prevalence, Patient

CINCINNATI, Aug. 9, 2023 /PRNewswire/ -- PatientPoint® today announced the launch of PatientPoint Audience Builder, a new precision targeting tool for point-of-care marketing campaigns designed to help life science brands find and reach every possible patient with relevant, meaningful messaging. By leveraging a medical claims-based targeting approach, PatientPoint Audience Builder enables life science brands to extend their reach to access diverse populations with the most relevant and inclusive messaging to empower moments that matter along their treatment journey.

Key Points: 
  • CINCINNATI, Aug. 9, 2023 /PRNewswire/ -- PatientPoint® today announced the launch of PatientPoint Audience Builder , a new precision targeting tool for point-of-care marketing campaigns designed to help life science brands find and reach every possible patient with relevant, meaningful messaging.
  • By leveraging a medical claims-based targeting approach, PatientPoint Audience Builder enables life science brands to extend their reach to access diverse populations with the most relevant and inclusive messaging to empower moments that matter along their treatment journey.
  • "Audience Builder gives brands the opportunity to find, reach and engage every possible patient."
  • By analyzing medical claims data, PatientPoint's proprietary Audience Builder technology enables life science brands to more confidently reach every possible patient seen by the 140,000 healthcare providers in the PatientPoint network.